Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martina Dalla Via
Discovery of Wt RET and V804M RET Inhibitors: From Hit to Lead
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Related publications
Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
C-Ret Molecule in Malignant Melanoma From Oncogenic RET-Carrying Transgenic Mice and Human Cell Lines
PLoS ONE
Multidisciplinary
Positive Germline Selection in Pedigrees With Multiple Endocrine Neoplasia Type 2 Carrying V804M Mutation in the RET Gene
World Journal of Oncology
Cancer Research
Oncology
TBC1D32-RET: A Novel RET Oncogenic Fusion in Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Variable Expressivity of Familial Medullary Thyroid Carcinoma (FMTC) Due to a RET V804M (GTGG→ATG) Mutation in Two Families: Reluctance of Gene Carriers to Accept Prophylactic Thyroidectomy
Genetics in Medicine
Medicine
Genetics
MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient With Acquired RET Rearrangement
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Targeting the Receptor Tyrosine Kinase RET Sensitizes Breast Cancer Cells to Tamoxifen Treatment and Reveals a Role for RET in Endocrine Resistance
Oncogene
Cancer Research
Genetics
Molecular Biology
Targeting RET-driven Cancers: Lessons From Evolving Preclinical and Clinical Landscapes
Nature Reviews Clinical Oncology
Oncology
